Friday, September 25, 2020 8:37:46 AM
The next Monday the stock started it's fall..you know the rest.
It is not unusual for CEO's to publicly say their stock is undervalued...no word from Thero.
In fact since July of last year at what he call a mid year report he pumps the stock by raising sales estimates followed by dilution...whare was this year's mid year report?...with so much going on there was not one...Why?
Since last July Thero has said he will deliver shareholder value...nothing....he has not done or said anything positive...quite the contrary...his actions are more of a short seller trying to sabotage the stock.
When was the last time you ever heard a CEO of a public Co actually say the did not settle because it did not meet shareholders expectations in an email to a retail investor who asked for clarification on 2 subjects that had nothing to do with settlement...it was beyond outrageous....there really are not words that describe his stupidity...and yet it is followed up by him saying the shareholders he heard from wanted to GIA in EU...both cases he just can't say we are doing what we believe is best....he buffers his decision by throwing the shareholders under the bus..
This Co. Shows total destain for shareholders....no transparency...even when he makes statements they are incredibly gauge and left for people guessing what he means.
This stock is at 3.60 not because Vascepa is a bad drug but because Thero is an inexperienced, underqualified ceo that was picked because he was an AMRN man...the BOD by picking him as ceo are as responsible for this hell hole as he is....it is a joke.
The blame is not on 4 judges it is on this overconfident inflexible cocky Ceo and BOD....this should and could have been settled...you ever wonder why the CEO of Hikma had such distain and no respect for Thero..unless proven otherwise it is and has been my opinion Thero would not budge off of Teva like terms....why could Apotex not get a better deal...Teva settled in 2018 before R-IT and FDA approval...certainly AMRN should have conceded something.
Because he has no experience it's much harder to be flexible as you don't know if your doing what's right or wrong.
This was the last man on earth that should have been leading this company.
It's easy to keep blaming the judges but it was actually Covington that screwed this case up royally and Thero....all overconfident as nobody wanted to tell them the king did not have any clothes on and that to risk the company in the 9th district with a liberal judge could be a liability...
Line everything up over time and it's plain as light we are either cursed by one bad event after another with the most incompetent Bod, ceo, Kennedy, lawyers or something is up..
Either way it does not matter much...we've been getting screwed so long most of us are numb.
Bon chance mon ami
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM